Revolution Medicines Inc. Common Stock vs YieldMax Magnificent 7 Fund of Option Income ETFs — how do they compare? Revolution Medicines Inc. Common Stock trades at $188.5 (market cap $40.32B), while YieldMax Magnificent 7 Fund of Option Income ETFs trades at $11.52 (market cap $296.92M). The key difference: Revolution Medicines Inc. Common Stock is far larger — about 135.8× YieldMax Magnificent 7 Fund of Option Income ETFs's market cap, and Revolution Medicines Inc. Common Stock is trading nearer its 52-week high, YieldMax Magnificent 7 Fund of Option Income ETFs nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Revolution Medicines Inc. Common Stock for 0 Days and YieldMax Magnificent 7 Fund of Option Income ETFs for 62 Days on average.
| RVMD | YMAG | |
|---|---|---|
Market Cap | $40.32B | $296.92M |
Volume | 4,855,734 | 1,023,545 |
Sector | Health | Income / Options Overlay |
52-Week High | $221.15 | $15.68 |
52-Week Low | $47.50 | $10.76 |
Typical Hold Time | 0 Days | 62 Days |
Enterprise Value | $37.02B | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
YMAG trades at $11.49, down 0.69% with a bullish technical signal supported by moving averages. The ETF maintains consistent weekly dividend distributions, though key valuation ratios remain unavailable. Recent news highlights ongoing distribution announcements and trading activity, with the stock showing moderate volatility within a tight $11-12 range.
The outlook remains cautiously optimistic given the bullish technical setup and income generation through dividends. However, risks include NAV stability concerns during earnings periods and dependency on underlying option strategies. Investors should weigh the high distribution yield against potential capital volatility in market downturns.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →YMAG is an actively managed 'fund of funds' that provides equal-weighted exposure to the seven YieldMax ETFs tracking the 'Magnificent 7' tech giants (Apple, Microsoft, Alphabet, Amazon, Nvidia, Meta, and Tesla). It seeks to generate high current income by harvesting option premiums across these leaders, offering a streamlined way to access concentrated tech volatility in an income-producing format.
Read more on YMAG →